Uniwersyteckie Centrum Kliniczne Trials

Uniwersyteckie Centrum Kliniczne	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Malecki, Maciej

METRE-PL, NCT05164341: Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects with PL

Recruiting

Europe, Canada, US, RoW

metreleptin, Placebo

Amryt Pharma

Partial Lipodystrophy

06/25

01/26

ECLip Registry, NCT03553420: Registry for Patients With Lipodystrophy

Recruiting

N/A

5000

Europe, RoW

University of Ulm, Sorbonne University, University Hospital, Lille, University of Cambridge, Endocrinology Research Centre, Moscow, University of Leipzig, University of Amsterdam, Dokuz Eylul University, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Rome Tor Vergata, University of Pisa, University of Santiago de Compostela, Università degli Studi del Piemonte Orientale Amedeo Avogadro, University Hospital Muenster, Szeged University, Centro Hospitalar do Porto, University Medical Centre Ljubljana, Medical University of Vienna, Ostschweizer Kinderspital

Lipodystrophy Acquired, Lipodystrophy Congenital

01/68

Siuda, Joanna

NCT05357989 / 2022-001542-38: A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Completed

523

Europe, US

buntanetap/posiphen, Posiphen Tartrate, ANVS401, Placebo

Annovis Bio Inc., TFS Trial Form Support

Parkinson's Disease, Idiopathic

12/23

NCT05814523: To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Withdrawn

Europe, RoW

Ganaxolone, Placebo, Standard of care

Marinus Pharmaceuticals

Refractory Status Epilepticus

08/24



	Diseases Companies Products Productz Mechanisms of Action Sites